First, Novo Nordisk is expanding its program to sell Wegovy GLP-1 weight loss drugs at discounted prices. Second, Novo is ...

Shares of Eli Lilly & Co. LLY rallied 3.26% to $864.90 Monday, on what proved to be an all-around great trading session for ...

It's hard to overstate how much demand could be out there for effective weight management drugs. The global anti-obesity drug ...

Despite further analyses in a subgroup of patients with no copies of the ApoE4 gene, known to have a lower risk of ARIA, the ...

Eli Lilly (LLY) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to review some of ...

If  you're looking for a low-risk growth stock that also happens to be outperforming the S&P 500 (^GSPC-0.33%) so far this ...

In the latest trading session, Eli Lilly (LLY) closed at $852.35, marking a -1.45% move from the previous day. The stock's performance was behind the S&P 500's daily gain of 0.16%. On the other hand, ...

Discover why Eli Lilly and Company is set for a strong 2024 with a robust pipeline, solid financials, and strategic growth ...

Novo Nordisk’s (NVO) stock has dropped by 25% in March (on the Copenhagen exchange) to put it on track for its biggest ...

We recently published a list of Top 10 Stocks to Buy According to Two Sigma Investments. In this article, we are going to ...

This was the stock's second consecutive day of losses.

Eli Lilly LLY -2.21% Get Free Report has outperformed the market over the past 20 years by 6.51% on an annualized basis ...